Sophia Genetics SA - (SOPH) closed at $7.35 on October 23, 2026, up 4.3% from the previous close, on volume of 440,938 shares (30-day average 673,033).
Data as of October 23, 2026.
23-Oct-2026
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026
PRNewswire (Tue, 20-Oct 8:01 AM ET)
PRNewswire (Thu, 8-Oct 9:01 AM ET)
Globe Newswire (Thu, 8-Oct 9:00 AM ET)
SOPHiA GENETICS Reports Second Quarter 2026 Results
PRNewswire (Tue, 4-Aug 6:45 AM ET)
PRNewswire (Tue, 4-Aug 6:15 AM ET)
SOPHiA GENETICS’ $50 Million Share Offering Draws Market Attention: What the Numbers Reveal
Market Chameleon (Wed, 17-Jun 7:16 AM ET)
Market Chameleon (Mon, 12-Jan 3:43 AM ET)
Market Chameleon (Thu, 16-Oct 3:56 AM ET)
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.
As of October 23, 2026, SOPH stock price climbed to $7.35 with 440,938 million shares trading.
SOPH has a beta of 1.32, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.08 to the broad based SPY ETF.
SOPH has a market cap of $616.63 million. This is considered a Small Cap stock.
Last quarter Sophia Genetics SA - reported $23 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.08.
In the last 3 years, SOPH traded as high as $8.98 and as low as $2.58.
The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, GWX, MEDI, GNMX.
SOPH has outperformed the market in the last year with a price return of +78.4% while the SPY ETF gained +14.3%. SOPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +21.5% and -0.8%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
SOPH support price is $6.72 and resistance is $7.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.
